Dossier Changes in Russia and the 90 Working Day Rule
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Under pp. 112 and 120 of Resolution No. 1684, once data relating to a device or its documents changes, an application for the corresponding change to the registration documents must be filed within 90 working days. The deadline is counted in working days, and the later the application is filed, the more easily the situation slides into the suspension chain of p. 137. Changes follow two procedural tracks: changes not requiring expert review (the situations of p. 111) and changes requiring expert review (the situations of p. 119 and others), and the two tracks differ in both timelines and state fees. Knowing in advance which track a change will take is the basis for realistic project scheduling.
The 90-working-day window makes change management a standing internal discipline rather than a regulatory formality. Every relevant change must be detected, timed and filed within a defined internal workflow, and because supplementation and responses to expert queries do not count into the procedural durations, calendar time can stretch far beyond the statutory figures when filings are incomplete. Packaging changes into consolidated applications reduces both the number of supplementation cycles and the accumulated fees.
The counter also behaves differently from a calendar deadline: 90 working days skip weekends and Russian public holidays, so the same clock can represent four to five calendar months depending on where it starts. Teams that manage the deadline in calendar days systematically overestimate the time available. The safe approach is a conversion into calendar dates at the moment the change is discovered, with the resulting date entered in the project tracker as a hard milestone, and with an internal buffer so that the filing happens well before the statutory limit rather than on it.
2. Legal basis
The instruments governing changes to registration documents are summarised below.
| Regulation | Number | Date | Provisions |
|---|---|---|---|
| Government Resolution of the Russian Federation on the State Registration Rules for Medical Devices | Government Resolution of the Russian Federation No. 1684 | November 30, 2024 | p. 111 (changes without expert review), pp. 112, 120 (deadlines), pp. 114–132 (timelines of the two procedures), p. 137 (suspension and revocation) |
| Government Resolution of the Russian Federation (extension of validity) | Government Resolution of the Russian Federation No. 2214 | December 30, 2025 | Rules extended until December 31, 2028 |
| Protocol amending the Agreement of 2014 | Protocol | Signed December 29, 2025 | Applications under national rules until December 31, 2028 |
| Tax Code of the Russian Federation | Tax Code of the Russian Federation, Article 333.32.2 | Current version | State fees for changes |
3. Expert insights
Insight 1: the durations of the two tracks differ markedly. The track without expert review runs: completeness check 5 working days, decision to initiate 3 working days, review and entry into the register 10 working days. The track with expert review runs: completeness check 5 working days, decision to initiate 3 working days and issuance of the review assignment 3 working days, expert review of the change 15 working days, evaluation of the conclusion and decision 10 working days. The difference of a single procedural stage translates into weeks of calendar time per filing, which is why the initial classification of each change is worth doing carefully and early.
Insight 2: supplementation and responses do not count into the procedural durations. Eliminating deficiencies takes up to 30 working days and answering expert queries up to 50 working days, and these periods are excluded from the durations above. A company that repeatedly triggers deficiencies therefore experiences calendar timelines far longer than the sum of the statutory figures. The remedy is front-loading quality: complete dossiers, well-prepared responses and early expert consultation shorten the real calendar even though they leave the statutory numbers untouched.
Insight 3: which changes need no expert review is conditional. For example, a change of production address caused by street renaming or renumbering of buildings is expressly listed in p. 111, and Class 1 and non-sterile Class 2a devices may use the simplified route under item “b” of p. 111 within the validity of the QMS evaluation. Beyond these cases, most substantive changes still require expert review. The conditional nature means each change must be assessed individually against the text of the rules, not against a remembered list.
A useful discipline is a quarterly change review in which the product, the label, the instructions for use, the manufacturing sites and the software versions are compared against the registered documents, and every detected difference is logged with its discovery date and its planned filing. This turns the 90-working-day deadline from a legal risk into a routine queue: changes are batched, classified and filed in consolidated applications, and the state fees and review durations are forecast from the log. Without such a log, changes tend to surface late, individually and under time pressure, which is precisely the pattern that produces deficiencies and repeated supplementation.
4. Practical recommendations
- Establish an internal workflow of change trigger, timing and filing, and treat the date the change is discovered as the start of the 90-working-day clock.
- Prefer consolidated single filings over several scattered ones: repeated submissions consume additional supplementation and response cycles and increase fee expenditure.
- Start planning 2028 change matters in the second half of 2027 to avoid the queue at the end of the validity window.
- Classify each change against p. 111 and p. 119 before filing, and budget the state fee under Article 333.32.2 of the Tax Code accordingly.
- Keep evidence of the change discovery date in the project file, since the working-day deadline is measured from it.
5. Verification checklist
- □ The list of change trigger events is defined in the internal workflow
- □ The timing start uses the date of change discovery, managed against 90 working days
- □ It has been determined which procedure applies, with or without expert review, and the fees have been estimated
- □ Sufficient allowance is made for supplementation (30 working days) and query responses (50 working days)
- □ Change matters scheduled for 2028 have been started in advance
Regulatory information verified as of October 29, 2026.
GRZAN helps registered manufacturers manage changes to their Russian registration documents, from classifying each change against the tracks of Resolution No. 1684 and preparing consolidated filings within the 90-working-day deadline to estimating state fees and planning around the 2028 validity window. Our consultants keep your certificate current and your timeline predictable. For support with Russian registration changes and conformity documentation, contact us at info@grzanglobal.com.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us